Synthesis of an I-123 analog of A-85380 and preliminary SPECT imaging of nicotinic receptors in baboon

Nuclear Medicine and Biology

Volumn 26, Issue 2, 1999, Pages 201-207

  Musachio, John L ^a   Villemagne, Victor L ^a   Scheffel, Ursula A ^a   Dannals, Robert F ^a   Dogan, A Semih ^a   Yokoi, Fuji ^a   Wong, Dean F ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Iodine 123; Nicotinic acetylcholine receptor; SPECT

Indexed keywords

5 IODO 3 (2 AZETIDINYLMETHOXY)PYRIDINE I 123; IODINE 123; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; BINDING AFFINITY; CHOLINERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG SYNTHESIS; FRONTAL CORTEX; LIGAND BINDING; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RECEPTOR AFFINITY; RECEPTOR BINDING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; AZETIDINES; BRAIN; IODINE RADIOISOTOPES; MALE; MOLECULAR STRUCTURE; PAPIO; RADIOCHEMISTRY; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033019826     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00101-2     Document Type: Article

References (35)

1. Abreo M.A., Lin N.-H., Garvey D.S., Gunn D.E., Hettinger A.-M., Wasicak J.-T., Pavlik P.-A., Martin Y.C., Donnelly-Roberts D.L., Anderson D.J., Sullivan J.P., Williams M., Arneric S.P., Holladay M.W. Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. J. Med. Chem. 39:1996;817-825.
2. Bannon A.W., Decker M.W., Holladay M.W., Curzon P., Donnelly-Roberts D., Puttfarcken P.S., Bitner R.S., Diaz A., Dickenson A.H., Porsolt R.D., Williams M., Arneric S.P. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science. 279:1998;77-81.
3. Bottlaender M., Loc'h C., Kassiou M., Ottaviani M., Coulon C., Tavitian B., London E., Musachio J., Dannals R., Maziére B. In vivo PET study of nicotinic acetylcholine receptors (nAChR) with [Br-76]-bromoepibatidine. Soc. Neurosci. Abstr. 23:1997;382.
4. Chan S.M., Basmadjian G.P., Marten D.F., Sadek S.A., Magarian R.A., Grunder J.R., Ice R.D. Synthesis and biodistribution of radioiodinated-5-iodonicotine. J. Labelled Compd. Radiopharm. 20:1983;1017-1025.
5. Clauson-Kaas N., Mattern G. and Traber W. (1980) Process for producing 3-hydroxy-5-halopyridines. U. S. patent 4,192,946.
6. Corrigall W.A., Franklin K.B.J., Coen K.M., Clarke P.B.S. The mesolimbic dopaminergic system is implicated in the reinforcing properties of nicotine. Psychopharmacology. 107:1992;285-289.
7. 125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors. J. Pharmacol. Exp. Ther. 282:1997;445-451.
8. Ding Y.S., Gatley S.J., Fowler J.S., Volkow N.D., Aggrawal D., Logan J., Dewey S.L., Liang F., Carroll F.I., Kuhar M.J. Mapping nicotinic acetylcholine receptors with PET. Synapse. 24:1996;403-407.
9. 18F]fluoro-3-[(S)-2-azetidinylmethoxy]pyridine, a highly potent radioligand for in vivo imaging central nicotinic acetylcholine receptors. J. Labelled Compd. Radiopharm. 41:1998;451-463.
10. 18F]fluoro-3-[(S)-2-azetidinylmethoxy]pyridine, a novel highly potent radioligand for in vivo imaging central nicotinic acetylcholine receptors. J. Nucl. Med. 39S:1998;21P.
11. 3H]nicotine binding in human cerebral cortex Comparison between Alzheimer's disease and the normal . J. Neurochem. 47:1986;1948-1954.
12. Grünwald F., Biersack H.-J., Kuchinsky W. Nicotine receptor mapping. Eur. J. Nucl. Med. 23:1996;1012-1013.
13. Holladay M.W., Wasicak J.T., Lin N.-H., He Y., Ryther K.B., Bannon A.W., Buckley M.J., Kim D.J.B., Decker M.W., Anderson D.J., Campbell J.E., Kuntzweiler T.A., Donnelly-Roberts D.L., Piattoni-Kaplan M., Briggs C.A., Williams M., Arneric S.P. Identification and initial structure-activity relationship of (R)-5- (2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors. J. Med. Chem. 41:1998;407-412.
14. 18F]A-85380) . J. Labelled Compd. Radiopharm. 41:1998;309-318.
15. 18F]fluoro-3(2(S)-azetidinylmethoxy)pyridine, a radioligand for in vivo imaging of central nicotinic acetylcholine receptors. Soc. Neurosci. Abstr. 23:1997;382.
16. 11C]A-84543 An enantioselective ligand for in vivo studies of neuronal nicotinic acetylcholine receptors . Life Sci. 63:1998;13-18.
17. Lin N.-H., Gunn D.E., Li Y.H., He Y., Bai H., Ryther K.B., Kuntzweiler T., Donnelly-Roberts D.L., Anderson D.J., Campbell J.E., Sullivan J.P., Arneric S.P., Holladay M.W. Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonist. Biorganic Med. Chem. Lett. 8:1998;249-254.
18. London E.D., Ball M.J., Waller S.B. Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia. Neurochem. Res. 14:1989;745-750.
19. Molina P.E., Ding Y.-S., Carroll F.I., Liang F., Volkow N.D., Pappas N., Kuhar M., Abumrad N., Gatley S.J., Fowler J.S. Fluoro-norchloroepibatidine preclinical assesment of acute toxicity . Nucl. Med. Biol. 24:1997;743-747.
20. Musachio J.L., Scheffel U., Finley P.A., Zhan Y., Mochizuki T., Wagner H.N. Jr, Dannals R.F. 5-[I-123/125]iodo-3-(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analog of A-85380 for in vivo studies of central nicotinic acetylcholine receptors. Life Sci. 62:1998;351-357.
21. Musachio J.L., Scheffel U., Zhan Y., Mochizuki T., Finley P., Xiao Y., Dávilia-García M.I., Kellar K.J., Dannals R.F. 5-[I-123/125]iodo-3-(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analog of A-85380 for in vivo studies of nicotinic acetylcholine receptors. J. Nucl. Med. 39S:1998;48P.
22. 125/123I]IPH A radioiodinated analog of epibatidine for in vivo studies of nicotinic acetylcholine receptors . Synapse. 26:1997;392-399.
23. Musachio J.L., Horti A., London E.D., Dannals R.F. Synthesis of a radioiodinated analog of epibatidine (±)-exo-2-(2-iodo-5-pyridyl)-7-azabicyclo[2.2.1]heptane for in vitro and in vivo studies of nicotinic acetylcholine receptors . J. Labelled Compd. Radiopharm. 39:1997;39-48.
24. 11C-nicotine binding in normal and Alzheimer brains - In vivo assessment using positron emission tomography. Alzheimer Dis. Assoc. Disord. 9:1995;21-27.
25. Norberg A., Alafuzoff I., Winblad B. Nicotinic and muscarinic subtypes in the human brain Changes with aging and dementia . J. Neurosci. Res. 31:1992;103-111.
26. 11C]nicotine in the human brain Difficulties in visualizing specific receptor binding in vivo . Psychopharmacology. 115:1994;31-36.
27. Nybäck H., Nordberg A., Långström B., Hallidin C., Hartvig P., Åhlin A., Swahn C.-G., Sedvall G. Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography. Prog. Brain Res. 79:1989;313-319.
28. 18F]fluoroethylepibatidine Ligands for the neuronal nicotinic receptor . J. Labelled Compd. Radiopharm. 37:1995;355P.
29. Riche D., Hantraye P., Guibert B., Naquet R., Loc'h C., Maziere B., Maziere M. Anatomical atlas of the baboon's brain in the orbito-meatal plane used in experimental positron emission tomography. Brain Res. Bull. 20:1988;283-301.
30. Saji H., Watanabe A., Magata Y., Ohmomo Y., Kiyono Y., Yamada Y., Iida Y., Yonekura Y., Konishi J., Yokoyama A. Synthesis and characterization of radioiodinated (S)-5-iodonicotine A new ligand for potential imaging of brain nicotinic cholinergic receptors by single photon emission computed tomography . Chem. Pharm. Bull. 45:1997;284-290.
31. Sullivan J.P., Donnelly-Roberts D., Briggs C.A., Anderson D.J., Gopalkrishnan M., Piattoni-Kaplan M., Cambell J.E., McKenna D.G., Molinari E., Hettinger A.-M., Garvey D.S., Wasicak J.T., Holladay M.W., Williams M., Arneric S.P. A-85380 [3-(2(S)-azitidinemethoxy)pyridine] In vitro pharmacological properties of a novel, high affinity α4β2 acetylcholine receptor ligand . Neuropharmacology. 35:1996;725-734.
32. 18F]fluoro-3[(S)-2-azetidinylmethoxy]pyridine and PET in baboons. J. Nucl. Med. 39S:1998;72P.
33. 18F]-labeled analog of epibatidine. J. Nucl. Med. 38:1997;1737-1741.
34. Warpman U., Nordberg A. Epibatidine and ABT 418 reveal selective losses of α4β2 nicotinic receptors in Alzheimer brains. NeuroReport. 6:1995;2419-2423.
35. Whitehouse P.J., Martino A.M., Antuono P.G., Kellar K.J. Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res. 371:1986;146-151.